Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation

Autor: Tom van der Poll, Nora S. Wolff, Alex F. de Vos, Floor Hugenholtz, Jacqueline M. Lankelma, W. Joost Wiersinga, Max C. Jacobs
Přispěvatelé: Graduate School, AII - Infectious diseases, Center of Experimental and Molecular Medicine, Infectious diseases
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Lipopolysaccharides
Lipopolysaccharide
Physiology
Neutrophils
Gut flora
Toxicology
Pathology and Laboratory Medicine
chemistry.chemical_compound
White Blood Cells
Mice
Medical Conditions
Antibiotics
Animal Cells
Immune Physiology
Natural Resources
Medicine and Health Sciences
Toxins
Immune Response
Lung
Innate Immune System
Multidisciplinary
medicine.diagnostic_test
biology
Antimicrobials
Interleukin
Drugs
respiratory system
Anti-Bacterial Agents
medicine.anatomical_structure
Water Resources
Cytokines
Medicine
Tumor necrosis factor alpha
Female
medicine.symptom
Cellular Types
Bronchoalveolar Lavage Fluid
Research Article
Inflammatory Diseases
Immune Cells
Science
030106 microbiology
Immunology
Toxic Agents
Bacterial Toxins
Acute Lung Injury
Inflammation
Microbiology
03 medical and health sciences
Signs and Symptoms
Microbial Control
medicine
Animals
Pharmacology
Blood Cells
Bacteria
business.industry
Interleukin-6
Gut Bacteria
Ecology and Environmental Sciences
Organisms
Biology and Life Sciences
Cell Biology
Molecular Development
medicine.disease
biology.organism_classification
respiratory tract diseases
Gastrointestinal Microbiome
Endotoxins
Mice
Inbred C57BL

Pneumonia
030104 developmental biology
Bronchoalveolar lavage
chemistry
Immune System
Clinical Medicine
business
Developmental Biology
Zdroj: PLoS ONE, Vol 15, Iss 11, p e0241748 (2020)
PLoS ONE
PLoS ONE, 15(11 November):e0241748. Public Library of Science
ISSN: 1932-6203
Popis: BackgroundAn increasing body of evidence is indicating that the gut microbiota modulates pulmonary inflammatory responses. This so-called gut-lung axis might be of importance in a whole spectrum of inflammatory pulmonary diseases such as acute respiratory distress syndrome, chronic obstructive pulmonary disease and pneumonia. Here, we investigate the effect of antibiotic disruption of gut microbiota on immune responses in the lung after a intranasal challenge with lipopolysaccharide (LPS).Methods/resultsC57Bl/6 mice were treated for two weeks with broad-spectrum antibiotics supplemented to their drinking water. Afterwards, mice and untreated control mice were inoculated intranasally with LPS. Mice were sacrificed 2 and 6 hours post-challenge, after which bronchoalveolar lavage fluid (BALF) and lung tissues were taken. Gut microbiota analysis showed that antibiotic-treated mice had a pronounced reduction in numbers and diversity of bacteria. A modest, but time consistent, significant increase of interleukin (IL)-6 release was seen in BALF of antibiotic treated mice. Release of tumor necrosis factor alpha (TNFα), however, was not statistically different between groups.ConclusionAntibiotic induced microbiota disruption is associated with alterations in host responses during LPS-induced lung inflammation. Further studies are required to determine the clinical relevance of the gut-lung axis in pulmonary infection and inflammation.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje